Table 3.
CSF and MRI characteristics with low versus high Rankin Scores at the final of the follow up
| |
Outcome Rankin |
p |
Total |
|
|---|---|---|---|---|
| <2 | ≥2 | |||
| N (%) |
51 (60) |
34 (40) |
|
85 (100) |
|
CSF (mean, SD) |
|
|
|
|
| Glucose, mmol/L |
3.5 (1.1) |
4 (1) |
0.035 |
3.7 (n:78) |
| Cell count, n/mm3 |
8.9 (24.1) |
27.8 (125.4) |
0.321 |
16.5 (n:77) |
| Protein, g/L |
0.4 (0.2) |
0.5 (0.2) |
0.389 |
0.5 (n:78) |
| OCB+, n (%) |
12/40 (30) |
3/20 (15) |
0.343 |
15/60 (25) |
| IgG index >0.7, n (%) |
8/33 (24.2) |
5 /22 (22.7) |
0.581 |
13/ 55 (23.6) |
|
MRI |
|
|
|
|
| Vertebral segments, n, mean (SD) |
1.7 (1.9) |
3.8 (3.3) |
0.003 |
2.5 (2.8) |
| LETM (%) |
(9.8) |
21 (61.8) |
<0.001a |
26 (30.6) |
| GD+, n (%) |
14/30 (46.6) |
8/21 (38.1) |
0.800 |
22/51 (43.1) |
| Time onset-MRI, Mean (SD), d | 9.84 (7.2) | 8.37 (7.5) | 0.408 | 9.26 (7.3) |
CSF: Cerebrospinal fluid.
OCB+: Positive oligoclonal band test.
MRI: Magnetic resonance imaging.
LETM: Longitudinally extensive transverse myelitis.
GD+: Gadolinium enhancement.
SD: standard deviation.
aSignificant after Bonferroni correction.